Kannalife scientist Dr. Doug Brenneman and CEO Dean Petkanas were interviewed by journalist Harry Smith on Dateline NBC Special “Growing Promise” which aired on Sunday May 20, 2018. The topics discussed were cannabidiol (cbd), the 507 Patent (#6630507) “Cannabinoids as […]
Dr. Sanjay Gupta interviews Kannalife Sciences CEO Dean Petkanas and the exclusive license to the US Government’s patent on Cannabis. “Cannabinoids as Antioxidants and Neuroprotectants”. Kannalife is working on two (2) distinct disease indications that effect the Brain. One is […]
Condition at Center of NFL Lawsuit Targeted by Medical Marijuana Company A plant-based pharmaceutical company is working on developing a medical marijuana treatment for chronic traumatic encephalopathy (CTE), a degenerative disease that affects people—particularly athletes—who have suffered repeated head trauma. […]
Aug. 4 –- Kannalife Sciences Founder Thoma Kikis and Leafly CEO Brendan Kennedy discuss using cannabinoid–based therapeutics to treat chronic traumatic encephalopathy and Leafly’s New York Times marijuana ad. They speak on “Street Smart.” (Source: Bloomberg)
July 8 (Bloomberg) — Thoma Kikis, co-founder of KannaLife Sciences, discusses the regulation of cannabis and Cannabinoid Therapeutics with Pimm Fox on “Taking Stock.” (Source: Bloomberg)
